July 4 (Reuters) - REDCARE PHARMACY NV RDC.DE :
* STRONG ACCELERATION OF E-RX SALES IN GERMANY FOR REDCARE
PHARMACY, FROM 7% GROWTH IN Q1 TO 37% IN Q2.
* TOTAL SALES REACHED EUR 560M IN Q2, UP 33% YEAR OVER YEAR
* Q2 NON-RX SALES TOTALED EUR 390M, STEADY CONTINUATION OF
FAST
GROWTH, UP 21% YEAR OVER YEAR
* ACTIVE CUSTOMER BASE EXPANDED TO 11.6M, UP 0.4M IN Q2 AND
1.4M
IN ONE YEAR
* TOTAL GROUP SALES INCREASED 33.3% TO EUR 560 MILLION (Q2
2023:
EUR 420 MILLION)
* YEAR-TO-DATE SALES TO EUR 1,120 MILLION AND GROWTH TO
41.4% (H1
2023: EUR 792 MILLION)
Source text for Eikon: ID:nEQ8nm1ZSa
Further company coverage: RDC.DE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))